This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Stock Offerings: Two Harbors

( EXCO Resources item corrected to note shares were issued under private placements.)

NEW YORK ( TheStreet) -- Two Harbors Investment (TWO - Get Report) lost ground in early trading Monday after the company resumed a proposed stock offering it had cancelled on Friday.

Two Harbors Investment said it will resume a public offering of common stock, revising the number of shares to be offered to 11 million.

On Friday, Two Harbors cancelled its proposed public offering of 14 million shares of common stock, having determined that the available share price "would result in an unacceptable dilution of book value to existing shareholders."

Shares of Two Harbors were down 2.1% to $9.01, retracing some of Friday's 5% increase.

Several other stocks were dropping on secondary offering announcements. Bovie Medical (BVX - Get Report) sank nearly 7% to $5.36 after the company will sell 571,429 shares at a price of $5.25 as part of a $3 million private placement with institutional investors. Bovie Medical President Andrew Makrides said the participation of institutional investors "is evidence of the confidence the investment community has placed in our company."

RegeneRx Biopharmaceuticals (RGN) sank by 7.3% to 53 cents after the company said late Friday that it intends to sell units consisting of common stock and warrants to purchase shares. RegeneRx said the size of the offering and the pricing of both the common stock and the exercise price of the warrants will be determined at the pricing of the offering.

On the other hand, American Capital (ACAS - Get Report) surged 10.1% to $5.87 after the company agreed to sell about 58.3 million common shares, including 43.7 million shares to funds and accounts managed by hedge fund Paulson & Co., as part of a $295 million registered direct offering of common stock priced at $5.06 per share.

Proceeds from the offering for investment and lending activities and to repay debt, American Capital said.

Elsewhere, EXCO Resources (XCO - Get Report) slipped 0.9% to $19.76 after the company renewed the registration of securities previously issued by EXCO in two separate private placements.

EXCO said it is not offering to sell or otherwise issue any securities and would not receive any proceeds if such shareholders were ever to elect to sell any shares.

Biolase Technology (BLTI) slid by 2% to $1.94 after the company filed late Friday for a $9.5 million mixed shelf offering.

EntreMed (ENMD) dropped 1.7% to 60 cents after the company priced a registered direct offering of roughly 5.79 million shares at 51.8 cents per share for net proceeds of $2.8 million. EntreMed said it will use the net proceeds for further clinical development of its Aurora A/angiogenic kinase inhibitor, ENMD-2076. EntreMed recently announced the initiation of a Phase 2 study in ovarian cancer patients after encouraging Phase 1 results

-- Written by Robert Holmes in Boston.

Follow Robert Holmes on Twitter and become a fan of on Facebook.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ACAS $15.80 1.48%
BVX $1.97 3.14%
ENMD $0.90 0.00%
TWO $7.83 -0.63%
XCO $1.52 3.40%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs